Literature DB >> 28743580

Comparison of balance strategies in mountain climbers during real altitude exposure between 1.500m and 3.200m: Effects of age and expertise.

Anne-Violette Bruyneel1, Arnaud Humbert2, Marc Bertrand2.   

Abstract

PURPOSE: The aim of this study was to estimate the effect of altitude (1500m vs. 3200m) on balance strategies, and to determine the influence of age (> or <40 years) and expertise (> or <20days of mountain climbing/year) on postural stability at altitude.
METHOD: Eighty-nine volunteer mountaineers were tested at 1500m, 3200m immediately after exiting the cable car and at 3200m following the climb and return. Double-leg stance with eyes closed and single-leg stance with eyes open were tested. The center of pressure (CoP) was recorded for 12.8s using a stabilometric force platform. Length, surface, ratio (length/surface), and average speed of the CoP, as well as lower limb loading were calculated. Groups and altitudes were compared using ANOVA. Significance was set to p<0.05.
RESULTS: CoP ratio was significantly higher during both balance conditions at 3200m compared to 1500m (p<0.05). Lower limb loading was symmetrical at 1500m but not at 3200m (p<0.05). There was no influence of age or expertise at 1500m (p=NS), however at 3200m, older subjects and subjects with less expertise had greater length and surface of the CoP, showing more instability (p<0.05).
CONCLUSION: Postural stability was immediately reduced on arrival at 3200m, particularly in subjects above the age of 40 years with less expertise.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Age; Altitude; Expertise; Mountaineers; Postural instability

Mesh:

Year:  2017        PMID: 28743580     DOI: 10.1016/j.neulet.2017.06.010

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  1 in total

Review 1.  Hypoxia and standing balance.

Authors:  Mathew I B Debenham; Janelle N Smuin; Tess D A Grantham; Philip N Ainslie; Brian H Dalton
Journal:  Eur J Appl Physiol       Date:  2021-01-23       Impact factor: 3.078

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.